Physician profile
Suneel Kumar
NPI 1275816654
$5,806.44
in general payments reported to CMS, 2019-2025
25 companies · $1,965 in 2025
The $1,965 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $420 · 2021: $229 · 2022: $235 · 2023: $799 · 2024: $618 · 2025: $1,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Travel and Lodging: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,061.06 |
| Travel and Lodging | $1,321.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,904.04 | 2019-2025 | Xience Skypoint, Dragonfly Opstar, Pressurewire |
| Edwards Lifesciences Corporation | $545.52 | 2019 | |
| Shockwave Medical, INC | $374.85 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $283.69 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $222.15 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $213.97 | 2019 | |
| Ge Healthcare | $173.70 | 2020 | |
| Abiomed | $162.56 | 2019-2024 | |
| Inari Medical, INC. | $135.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $134.31 | 2020-2023 | |
| Cardiovascular Systems INC. | $125.00 | 2020 | |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Medtronic, INC. | $80.68 | 2021-2025 | Onyx Frontier, Ffrangio |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Chiesi USA, INC. | $57.29 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | $39.63 | 2021 | |
| Amarin Pharma, INC. | $37.79 | 2021 | |
| La Jolla Pharmaceutical Company | $28.59 | 2019-2020 | |
| Heartflow, INC. | $27.93 | 2024 | |
| Sanofi-Aventis U.S. LLC | $23.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.50 | 2019 | |
| Allergan, INC. | $18.38 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.12 | 2021 | |
| Livanova USA, INC. | $16.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suneel Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.